| 000 -LEADER |
|---|
| fixed length control field |
03659nam a22004815i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150647.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100316s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781607615248 |
|
978-1-60761-524-8 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC254-282 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Totowa, NJ : |
| -- |
Humana Press : |
| -- |
Imprint: Humana Press, |
| -- |
2010. |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Stewart, David J. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Lung Cancer |
| Medium |
[electronic resource] : |
| Remainder of title |
Prevention, Management, and Emerging Therapies / |
| Statement of responsibility, etc |
edited by David J. Stewart. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XVI, 538p. 30 illus., 14 illus. in color. |
| Other physical details |
online resource. |
| 440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Current Clinical Oncology |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Molecular Pathology of Lung Cancer -- Tumor Microenvironment -- Racial and Ethnic Diversity in Lung Cancer -- Pharmacogenetics of Lung Cancer -- Lung Cancer Prevention -- Adjuvant and Neoadjuvant Therapy of NSCLC -- Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer -- Management of Advanced Non-small Cell Lung Cancer: Front Line Treatment -- Chemotherapy in Previously Treated Patients with Non-small Cell Lung Cancer -- Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer -- Angiogenesis Inhibitors in Lung Cancer -- Other Molecular Targeted Agents in Non-small Cell Lung Cancer -- Vaccine Therapy for Lung Cancer -- Gene-Based Therapies for Lung Cancer -- Lung Cancer Resistance to Chemotherapy -- Small Cell Carcinoma of the Lung -- Mesothelioma -- Advances in Oncology Clinical Research: Statistical and Study Design Methodologies -- Palliative Care for Patients with Lung Cancer -- The Future of Lung Cancer. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
This comprehensive resource provides authoritative knowledge of the most up-to-date prevention and treatment strategies for thoracic malignancies. Established and investigational therapies are placed in the context of tumor biology for a full understanding of the pharmacogenetics, etiology, and changing epidemiology of lung cancer. Expert clinicians detail the function of predictive and prognostic factors in the utilization of chemo-radiotherapy, adjuvant and neoadjuvant treatment, and targeted agents. The promises and potential pitfalls of investigational strategies are evaluated with exceptional insight and clarity, with unique attention paid to the mechanisms of drug resistance and targets for lung cancer treatment and prevention. Lung Cancer: Prevention, Management, and Emerging Therapies engages the entire spectrum of therapeutic modalities with focus on systemic approaches. Disease coverage includes newly diagnosed and recurrent non-small cell lung cancer, small cell carcinoma, and mesothelioma. Critical examination of the impact, methodology, and design of clinical trials is presented along with new paradigms for personalized approaches and individual risk assessment. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Radiotherapy. |
|
|---|
| Topical term or geographic name as entry element |
Pneumology. |
|
|---|
| Topical term or geographic name as entry element |
Biochemistry. |
|
|---|
| Topical term or geographic name as entry element |
Oncology. |
|
|---|
| Topical term or geographic name as entry element |
Medicine & Public Health. |
|
|---|
| Topical term or geographic name as entry element |
Oncology. |
|
|---|
| Topical term or geographic name as entry element |
Pneumology/Respiratory System. |
|
|---|
| Topical term or geographic name as entry element |
Radiotherapy. |
|
|---|
| Topical term or geographic name as entry element |
Medical Biochemistry. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781607615231 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-60761-524-8 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
